ELRIG's Therapeutic OLIGOs and European Chemical Biology Symposium 2023
Poster
11

Using heparin analogues to improve the transduction efficiency of gene therapy viral vectors

Abstract

Viral vectors have been extensively used in gene therapy applications. However, some challenges remain due to low viral transduction efficiency on certain tissues and cell types. To address this issue, many additives have been applied to reduce the toxicity and enhance the transduction efficiency such as polymers, lipids, peptides and polycationic compounds. It was known that polycationic additives such as protamine sulfate and polybrene enhance the transduction efficiency, whereas anionic molecules such as pyran and heparin inhibit the transduction efficiency. However, in this study, we found that when we used lower concentrations of heparin and its lower molecule analogues, we observed a significant increase in transduction efficiency in immune cells. These findings encourage us to conduct more investigations to understand the function that these compounds play in enhancing the viral uptake and the transduction efficiency.

supporting document

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2472